Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine. 2022 Mar 2;97:47-51. doi: 10.1016. Epub 2022 Mar 2.PMID: 35299070.
Hauser, RA, H Barkay, A Wilhelm, M Wieman, JM Savola, and MF Gordon. 2022. “Minimal Clinically Important Change in Abnormal Involuntary Movement Scale Score in Tardive Dyskinesia As Assessed in Pivotal Trials of Deutetrabenazine. 2022 Mar 2;97:47-51. Doi: 10.1016. Epub 2022 Mar 2.PMID: 35299070.”. Parkinsonism Relat Disord.